NCT06442462Active, not recruitingPhase 2
Study of SPG302 in Adults With Schizophrenia
A Randomized, Placebo-controlled, Double-blind Phase 2 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacodynamics of SPG302 in Adult Participants Diagnosed With Schizophrenia
Source: ClinicalTrials.gov · Last updated 6 Feb 2026
Brief summary (registry, in English)
This Phase 2 study described herein will evaluate the safety, efficacy, tolerability, and pharmacodynamics of SPG302 in adults with a primary diagnosis of schizophrenia.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 29 May 2024
- Start date
- 1 Aug 2024
- Primary completion date
- Mar 2026
- Lead sponsor
- Spinogenix
- Diseases
- Schizophrenia
- NCT number
- NCT06442462
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 32
- From 1 Aug 2024 to the primary completion date, Mar 2026
- 3 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receipt of investigational products within 30 days
Other illness
- Any physical or psychological condition that prohibits study completion
- Known cardiac disease
- Active or history of malignancy in the past 5 years
- History of clinically significant CNS event or diagnosis in the past 5 years.
Other
- Blood donation within 30 days
Who the study is looking for
- Age 18-65
- Primary diagnosis of schizophrenia
- Clinical laboratory values within normal range or \< 1.5 times ULN
- Currently prescribed only one antipsychotic medication, with stable dose for at least 4 weeks
- Able and willing to provide written informed consent
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Box Hill Hospital (Eastern health) Coordinator of this site? Confirm its status | Box Hill | Australia | Unknown status |
| Multidisciplinary Alfred Psychiatry Research Centre (MAPrc) Coordinator of this site? Confirm its status | Melbourne | Australia | Unknown status |
| CenExel CNS Coordinator of this site? Confirm its status | Garden Grove | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.